DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» PDGFRA
PDGFRA
Platelet-Derived Growth Factor Receptor Expression and Amplification in Choroid Plexus Carcinomas
Trastuzumab and Pertuzumab in Circulating Tumor DNA ERBB2-Amplified HER2-Positive Refractory Cholangiocarcinoma
Tumors
Original Article ERBB3, IGF1R, and TGFBR2 Expression Correlate With
PDGFRA Gene Rearrangements Are Frequent Genetic Events in PDGFRA-Amplified Glioblastomas
Intratumoral Heterogeneity of Receptor Tyrosine Kinases EGFR and PDGFRA Amplification in Glioblastoma Defines Subpopulations with Distinct Growth Factor Response
Supplementary Table 1. in Vitro Side Effect Profiling Study for LDN/OSU-0212320. Neurotransmitter Related Steroids
Unveiling the Molecular Mechanisms Regulating the Activation of the Erbb Family Receptors at Atomic Resolution Through Molecular Modeling and Simulations
Platelet-Derived Growth Factor Isoform Expression in Carbon Tetrachloride
Original Article C-Kit and PDGFRA Gene Mutations in Triple Negative Breast Cancer
Chondroitin Sulfate Synthase 1 Enhances Proliferation Of
Pdgfra) Is Deleted in the Mouse Patch (Ph) Mutation (Development/Dominant Spotting/Linkage Analysis/Human Homolog) DENNIS A
Novel Somatic Genetic Variants As Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients
5.01.534 Multiple Receptor Tyrosine Kinase Inhibitors
Research Article Identification of Differentially Expressed Kinase and Screening Potential Anticancer Drugs in Papillary Thyroid Carcinoma
Novel Tumor-Specific Mutations in Receptor Tyrosine Kinase Subdomain IX Significantly Reduce Extracellular Signal-Regulated Kinase Activity
Mutational Profile of KIT and PDGFRA Genes in Gastrointestinal Stromal Tumors in Peruvian Samples
Distinct Effects of Ligand-Induced Pdgfra and Pdgfrb Signaling in the Human Rhabdomyosarcoma Tumor Cell and Stroma Cell Compartments
Top View
Mouse Platelet-Derived Growth Factor Receptor a Gene Is Deleted in WJ9H and Patch Mutations on Chromosome 5 E
Stromal Platelet-Derived Growth Factor Receptor a (Pdgfra) Provides a Therapeutic Target Independent of Tumor Cell Pdgfra Expression in Lung Cancer Xenografts
Association of ERBB Mutations with Clinical Outcomes of Afatinib- Or
Studies of PDGF Receptor Signaling in Vitro and in Vivo
Stromal Platelet-Derived Growth Factor Receptor a (Pdgfra) Provides a Therapeutic Target Independent of Tumor Cell Pdgfra Expression in Lung Cancer Xenografts
Gastrointestinal Stromal Tumors: What Do We Know Now? Christopher L Corless
Molecular Analysis of PDGFRA and PDGFRB Genes
A Novel Signaling Complex Between TROY and EGFR Mediates
Ephrin-B2 Controls Pdgfrb Internalization and Signaling
Breast Cancer Expressing the Activated HER2/Neu Is Sensitive to Gefitinib in Vitro and in Vivo and Acquires Resistance Through a Novelpoint Mutation in the HER2/Neu
Novel Therapeutic Inhibitors of the C-Met Signaling Pathway in Cancer Joseph Paul Eder,1George F
KIT Exon 11 and PDGFRA Exon 18 Gene Mutations in Gastric GIST
Coactivated Platelet-Derived Growth Factor Receptor Α and Epidermal Growth Factor Receptor Are Potential Therapeutic Targets in Intimal Sarcoma
Cell Death Or Survival Promoted by Alternative Isoforms of Erbb4 Maria Sundvall,*†‡ Ville Veikkolainen,*‡§ Kari Kurppa,* Zaidoun Salah,ሻ Denis Tvorogov,* E
The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST)
Combinatorial Targeting of FGF and Erbb Receptors Blocks Growth and Metastatic Spread of Breast Cancer Models Issa Et Al
PDGFRA-Associated Chronic Eosinophilic Leukemia
Molecular Intelligence Summary MI-2013-12-26.0
Hotspot Mutations Detectable by Next-Generation Sequencing In
ERBB4 Promotes the Progression of Inflammatory Breast Cancer Through Regulating PDGFRA
Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response
Practical Molecular Pathology of the GI Tract Part 2
PDGFRA Gene Platelet Derived Growth Factor Receptor Alpha
Platelet-Derived Growth Factor Receptors Differentially Inform Intertumoral and Intratumoral Heterogeneity
Paradoxical Activation of Locked-Dimer Erbb Receptors 1
Ephb4 Overexpression in B16 Melanoma Cells Affects Arterial- Venous Patterning in Tumor Angiogenesis
Dynamic and Nuclear Expression of Pdgfra and IGF-1R in Alveolar Rhabdomyosarcoma
Eph Receptors As Therapeutic Targets in Glioblastoma
The Prognostic Effects of Somatic Mutations in ER- Positive Breast Cancer
Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma
PDGFRA Alterations in Cancer: Characterization of a Gain-Of-Function V536E Transmembrane Mutant As Well As Loss-Of-Function and Passenger Mutations
Immunohistochemical Heterogeneity of Breast Carcinomas Negative for Estrogen Receptors, Progesterone Receptors and Her2/Neu (Basal-Like Breast Carcinomas)
Eosinophilia Panel by FISH
Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine
Therapeutic Potential of TAS-115 Via C-MET and Pdgfrα
Pdgfrβ Reverses Ephb4 Signaling in Alveolar Rhabdomyosarcoma
Eph/Ephrin Signaling and Biology of Mesenchymal Stromal/Stem Cells
Induction of Endoplasmic Reticulum Stress by Sorafenib and Activation of NF-Kb by Lestaurtinib As a Novel Resistance Mechanism in Hodgkin Lymphoma Cell Lines
Mutational Spectrum and Classification of Novel Mutations in Patients with Metastatic Gastrointestinal Stromal Tumours
Platelet-Derived Growth Factor Alpha Mediates the Proliferation of Peripheral T-Cell Lymphoma Cells Via an Autocrine Regulatory Pathway
RECEPTOR TYROSINE KINASES in SINONASAL UNDIFFERENTIATED CARCINOMAS—EVALUATION for EGFR, C-KIT, and HER2/Neu EXPRESSION
Update on Molecular Genetics of Gastrointestinal Stromal Tumors
Sebaceous Carcinoma of Skin Expressing KIT and PDGFRA
Simultaneous Targeting of Eph Receptors in Glioblastoma
Platelet-Derived Growth Factor C Promotes Revascularization in Ischemic Limbs of Diabetic Mice
Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis As Target for Antitumor and Antiangiogenic Therapy
Precision Gemonic Profiling Gene Panels
Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
Tyrosine Kinase Receptors in Oncology
Co-Targeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma